SCHEMBL14720768

SCHEMBL14720768

COCCS(=O)(=O)c1ccc(C=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.44
HRH3 Q9Y5N1 5/20 0.40
GAA P10253 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MLNR O43193 1/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 1/20 0.36
SRD5A2 P31213 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
LOX P28300 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720491 0.93 HRH3 (0.45) KCNH2HRH3GAAKDM4ETP53
SCHEMBL14720472 0.89 ALDH1A1 (0.38) KCNH2HRH3GAAKDM4ETP53
SCHEMBL14721060 0.77 KCNH2 (0.43) KCNH2HRH3KDM4ETP53ALDH1A1
SCHEMBL14720413 0.76 LTA4H (0.38) HRH3CYP2D6SRD5A2
SCHEMBL14720718 0.76 HSD11B1 (0.51) KCNH2HRH3GAAKDM4EALDH1A1
SCHEMBL14720578 0.76 KDM4E (0.47) HRH3GAAKDM4EALDH1A1CYP2D6
SCHEMBL14720573 0.76 SRD5A2 (0.37) HRH3ALDH1A1SMN1; SMN2MLNRCYP2D6
SCHEMBL14731083 0.74 SRD5A2 (0.46) HRH3GAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL14720467 0.74 HRH3 (0.34) HRH3ALDH1A1SRD5A2KDM2BMEN1
SCHEMBL14721184 0.72 POLB (0.39) HRH3GAAKDM4EALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed